ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Japan to ready 1m doses of coronavirus vaccine for swift distribution

AnGes-led team ramps up capacity while product is still under development

Takara Bio will produce more precursors for AnGes's coronavirus vaccine. (Photo courtesy of Takara Bio)

KYOTO -- A team led by Japanese biotech venture AnGes will ready production capacity for 1 million doses of coronavirus vaccines by March, a fivefold increase from the original plan, in order to ensure swift access to the domestic population. 

As top pharmaceutical companies in the U.S. and elsewhere rush to set up facilities capable of producing billions of doses of vaccines, there is no guarantee that Japan can import them. The government hopes to counter any second wave of infections by building production capacity while vaccines are still in the development stage.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more